Log In
Print this Print this

Actyve zolmitriptan delivery system

  Manage Alerts
Collapse Summary General Information
Company Vyteris Inc.
DescriptionZolmitriptan delivered using Actyve transdermal iontophoresis technology
Molecular Target Serotonin (5-HT1D) receptor ; Serotonin (5-HT1B) receptor
Mechanism of ActionSerotonin (5-HT1B) receptor agonist; Serotonin (5-HT1D) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMigraine
Indication DetailsTreat migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today